BAYER AG NA O.N. news, videos and press releases - Page 3
For more news please use our advanced search feature.
BAYER AG NA O.N. - More news...
BAYER AG NA O.N. - More news...
- Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
- Judicial Panel Rejects Bayer Monsanto Attempt to Thwart Fair Settlement for Roundup-Cancer Victims
- Huma collaborates with Bayer to advance precision treatment for lung cancer
- BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
- Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures
- 111, Inc. Deepens Partnership with Bayer Healthcare
- Fears Nachawati Law Firm: Chorus Grows for Bayer CEO's Resignation as Juries Return Verdicts in Roundup Cancer Cases
- DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer announces five-point plan to effectively address potential future Roundup(TM) claims
- DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
- DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer announces agreements to resolve major legacy Monsanto litigation
- Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business
- WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
- Bayer and Daré Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene ®, an Investigational Hormone-Free, Monthly Contraceptive
- Bayer AG and Monsanto Look to Minimize Losses from Cancer Victims' Exposure to Roundup
- Bayer Trendlines Ag Innovation Fund Co-invests With Trendlines in ProJini Agchem
- Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
- Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
-
Canada’s $500M Bayer lawsuit ‘sends a message’ – journalist
- Bayer Fund helps Canadian farmers strengthen rural communities through its Canada’s Farmers Grow Communities Program
-
Bayer up after delay of cancer linked RoundUp trial
- Bayer G4A Partners With Wellthy Therapeutics
- Bayer G4A Partners With Wellthy Therapeutics
- Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results
- Bayer Fund shares over $100,000 in funding with students through its Opportunity Scholarship Program
- Aleve® Joins IRONMAN® `Ohana As Partner At The 2019 Vega IRONMAN® World Championship
- Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform
- Lynda and Stewart Resnick Donate $10 Million for Establishment of Resnick Center for Herbert Bayer Studies on Aspen Institute Campus
- Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targets
- Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
-
Bayer looks to turn around toxic Monsanto acquisition | DW News
